- Report
- November 2022
- 408 Pages
Global
From €3179EUR$3,600USD£2,746GBP
- Report
- October 2022
- 227 Pages
Global
From €3179EUR$3,600USD£2,746GBP
- Report
- February 2025
- 150 Pages
Global
From €4283EUR$4,850USD£3,699GBP
- Report
- April 2023
- 150 Pages
Global
From €4283EUR$4,850USD£3,699GBP
- Training
- July 2024
- 2 Days
Global
From €1198EUR$1,357USD£1,035GBP
€1410EUR$1,597USD£1,218GBP
- Report
- October 2025
- 81 Pages
Saudi Arabia
From €4283EUR$4,850USD£3,699GBP
- Report
- August 2025
- 80 Pages
From €3047EUR$3,450USD£2,631GBP
- Webinar
- May 2023
- 90 Minutes
Global
- Report
- September 2020
- 700 Pages
Global
From €4327EUR$4,900USD£3,737GBP
- Training
- 8 Hours
Global
From €1500EUR$1,699USD£1,296GBP
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global

Process Development in biotechnology is the process of designing, optimizing, and validating manufacturing processes for biopharmaceuticals. It involves the development of processes for the production of biopharmaceuticals, such as monoclonal antibodies, recombinant proteins, and vaccines. The process development process includes the development of analytical methods, process characterization, process optimization, and process validation. It also involves the development of process control strategies, such as process monitoring and process control systems.
Process development is a critical step in the development of biopharmaceuticals, as it ensures that the product is safe, effective, and of high quality. It is also important for the efficient and cost-effective production of biopharmaceuticals.
Companies in the Process Development market include Merck, Pfizer, Novartis, Amgen, and Genentech. Show Less Read more